RT Journal Article
SR Electronic
T1 Vapor H<sub>2</sub>O<sub>2</sub> sterilization as a decontamination method for the reuse of N95 respirators in the COVID-19 emergency
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.11.20062026
DO 10.1101/2020.04.11.20062026
A1 Oral, Ebru
A1 Wannomae, Keith K.
A1 Connolly, Rachel
A1 Gardecki, Joseph
A1 Leung, Hui Min
A1 Muratoglu, Orhun
A1 Griffiths, Anthony
A1 Honko, Anna N.
A1 Avena, Laura E.
A1 McKay, Lindsay G. A.
A1 Flynn, Nick
A1 Storm, Nadia
A1 Downs, Sierra N.
A1 Jones, Ralph
A1 Emmal, Brandon
YR 2020
UL http://medrxiv.org/content/early/2020/06/26/2020.04.11.20062026.abstract
AB There are a variety of methods routinely used in the sterilization of medical devices using hydrogen peroxide (H2O2) including vaporization, plasma generation and ionization. Many of these systems are used for sterilization and are validated for bioburden reduction using bacterial spores.Here, we explored the benefits of using vaporized H2O2 (VHP) treatment of N95 respirators for emergency decontamination and reuse to alleviate PPE shortages for healthcare workers in the COVID-19 emergency. The factors that are considered for the effective reuse of these respirators are the fit, the filter efficiency and the decontamination/disinfection level for SARS-CoV-2, which is the causative virus for COVID-19 and other organisms of concern in the hospital environment such as methicillin-resistant Staphylococcus aureus or Clostridium difficile. WE showed that the method did not affect fit or filter efficiency at least for one cycle and resulted in a &gt;6 log reduction in bacterial spores and &gt;3.8 log reduction in the infectious SARS-CoV2 load on N95 respirators.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no external funding for the study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is non-clinical, esperimental study. The data are presented in the preprint. Any other details can be accessed by contacting the corresponding author.